To complement their preclinical findings, the level of expression of CD39 and CD73 in MDSCs, as well as CD8+ T cell function, was measured in patients with type 2 diabetes mellitus (T2DM) on metformin. This evidence concerns the gene CD8A and type 2 diabetes mellitus.